Pancreatic cancer accounts for 2.8% of new cancer cases worldwide and is projected to become by 2030 the second leading cause of cancer-related deaths. Patients of African ancestry appear to be at an increased risk for pancreatic ductal adenocarcinoma (PDAC), with worse severity and outcomes. The pu...
We used the lysate MS-CETSA Isothermal Dose-Response (ITDR) protocol to discover the interactions of Darapladib with proteins in Plasmodium falciparum and human red blood cells proteomes.
